Home > News By Company > RNCOS
Insulin Pen Market to Post Double Digit Growth in US
Insulin pen market in the US is forecasted to grow at a CAGR of over 10% during 2010-2012, on account of lower cost of insulin pens, says RNCOS.
(EMAILWIRE.COM, September 03, 2009 ) New Delhi, India - According to our new analytical study “Insulin Delivery Systems Market Analysis (2008-2012)”, the insulin pen market in the US is forecasted to grow at a CAGR of around 10.4% during 2010-2012. Currently, the market is characterized by emergence of new technologies which are accurate and less painful. Our research anticipates that this growth will be fuelled by low costs of these devices as compared to other ones.
Insulin syringes, traditionally dominating the US insulin delivery device market, still account for a very high market share. Most of the patients in the US visit family doctors rather than endocrinologist, and family doctors recommend them the traditional methods of insulin delivery, such as syringes. But now this trend is changing and people are preferring new devices over the traditional ones, as these are more cost-effective and less painful. However, it is the insulin pumps which are the biggest threat to the insulin pen market in the US as the market share of these pumps has increased substantially in the last five years.
As compared to the US, insulin pens are used more in Europe and Japan. It is observed that 17% of insulin units are delivered in the US through insulin pens, while this share is 95% and 88% in Japan and Europe respectively. The overall market for pen devices in the US is small as compared to that of syringes and pumps, but has a huge potential and has been steadily growing. In terms of type of pen used, disposable insulin pens dominate the market over refillable insulin pens.
Our study analyzes the key segments of industry to present the future scenario of the industry. According to our industry experts, companies should develop low cost delivery methods in order to grow in developing markets. It also provides detailed analysis of the factors which are fuelling the growth of insulin device market. Besides this, report also provides rational analysis and forecast on various segments and sectors of the industry.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM207.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
Insulin syringes, traditionally dominating the US insulin delivery device market, still account for a very high market share. Most of the patients in the US visit family doctors rather than endocrinologist, and family doctors recommend them the traditional methods of insulin delivery, such as syringes. But now this trend is changing and people are preferring new devices over the traditional ones, as these are more cost-effective and less painful. However, it is the insulin pumps which are the biggest threat to the insulin pen market in the US as the market share of these pumps has increased substantially in the last five years.
As compared to the US, insulin pens are used more in Europe and Japan. It is observed that 17% of insulin units are delivered in the US through insulin pens, while this share is 95% and 88% in Japan and Europe respectively. The overall market for pen devices in the US is small as compared to that of syringes and pumps, but has a huge potential and has been steadily growing. In terms of type of pen used, disposable insulin pens dominate the market over refillable insulin pens.
Our study analyzes the key segments of industry to present the future scenario of the industry. According to our industry experts, companies should develop low cost delivery methods in order to grow in developing markets. It also provides detailed analysis of the factors which are fuelling the growth of insulin device market. Besides this, report also provides rational analysis and forecast on various segments and sectors of the industry.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM207.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
Contact Information:
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
|
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International Equityallianceir.com Penny Stocks to Watch Sign up for hot penny stock picks Gains of 500%+ possible! Premiumstockpicks.com/landing/ Your text Ads & PR Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. Read more on Text Ads & PR Your text Ads Here! Text Ads are only $289 per month. Ads are placed same day. More on Text Ads Advertising |




